logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
9/17/2021 8:38:44 AM Merck Gets Positive EU CHMP Opinion For KEYTRUDA In Combination With Chemotherapy
9/7/2021 9:27:02 AM Illumina Partners With Merck To Develop And Commercialize Tests For Use In Identifying Specific Cancer Mutations
9/7/2021 7:00:55 AM Merck: KEYTRUDA Approved In China In Combination With Chemotherapy For 1st-Line Treatment Of GEJ Cancer
8/26/2021 7:42:24 AM Merck's KEYTRUDA Receives Two New Approvals From Japan Pharmaceuticals And Medical Devices Agency
8/25/2021 7:10:32 AM Merck Announces VAXNEUVANCE Meets Key Immunogenicity And Safety Endpoints In Phase 3 Pivotal Trial
8/18/2021 7:41:55 AM Werewolf Therapeutics Collaborates With Merck On WTX-124 INDUKINE Program
8/10/2021 7:58:06 AM Merck: FDA Accepts Review For KEYTRUDA As Single Agent For MSI-H/dMMR Advanced Endometrial Carcinoma
8/10/2021 7:54:36 AM Merck: FDA Grants Priority Review To SBLA For KEYTRUDA As Adjuvant Therapy In Renal Cell Carcinoma